Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

By Lei Yang, M. Soonpaa, Eric Adler, T. K. Roepke, Steven J. Kattman, M. Kennedy, E. Henckaerts, Kristina Bonham, Geoffrey W. Abbott, R. Linden and 2 more. Nature, 2008

1,473 citations recorded by the source corpus.

Subfields: Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/5562d29f48653aabc8e2846741557e4f90315d04

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

Citations in the corpus

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells (2013, methodology): “Differentiation of Patient-Specific iPSCs into Cardiomyocytes Established iPSC lines from all subjects were differentiated into cardiomyocyte lineages (iPSC-CMs) using standard threedimensional (3D) EB differentiation protocols (Yang et al., 2008).”
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. (2011, background): “hiPSC-derived cardiomyocytes, as well as those derived from human embryonic stem cells (hESCs), also provide in vitro platforms for drug discovery and potentially for regenerative therapies (1, 43, 48).”
Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming (2012, neutral): “Using this method, approximately 70% of HES2 EBs spontaneously contract (Yang et al., 2008).”
Making muscle: skeletal myogenesis in vivo and in vitro (2017, background): “…hematopoietic progenitor specification and they established the role of Wnt signaling for mesoderm induction in vitro (Chadwick et al., 2003; Gadue et al., 2006; Johansson and Wiles, 1995; Kattman et al., 2011; Lindsley et al., 2006; Nakanishi et al., 2009; Yang et al., 2008; Zhang et al., 2008).”
Braveheart, a long non-coding RNA required for cardiovascular lineage commitment (2013, background): “Together, PdgfRa and Flk-1 define an early multipotent cardiovascular progenitor population (marked by MesP1), and their coexpression enhances cardiogenic potential (Kattman et al., 2006; Yang et al., 2008).”